Accountable care organizations (ACOs) which have contracts with commercial payors beat Medicare and Medicaid-only ACOs on several measures of performance in a study published in the October issue of Health Affairs.

In a deeply divided political climate, party or candidate affiliation can seemingly tell a lot about a person—or even determine what they might say or how they might act. Apparently even physicians aren’t immune, according to Yale researchers, the Washington Post reported.

Engineers from the University of Washington (UW) in Seattle have developed peptides able to transmit data from biological elements to artificial tools, reducing the need for invasive materials like metals and plastics, according to a report published Sept. 22 in Scientific Reports.

Brain training applications, often called brain games, have become ubiquitous on smartphones and tablets. These apps promise to improve your cognitive abilities by playing just a few minutes a day, but a pair of letters from two groups of scientists have sparked a debate on those promises.

Valencia Technologies, developers of medical devices, has received approval of the U.S. Food and Drug Administration (FDA) Investigational Device Exemption to being a study on its eCoin System for the treatment of drug-resistant hypertension.

Hospital-acquired infections are a serious concern for physicians and patients alike—they can be deadly, especially as antibiotic resistance grows, and their rate of incidence can be an important metric for CMS and other consumer reports when rating hospital quality and safety. And that’s not to mention the potential personal and legal risk some physicians could face. 

MILAN, Oct. 3, 2016 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it received CE Mark for its Acumen Hypotension Probability Indicator (HPI), a breakthrough technology that alerts clinicians to potential hypotension, or abnormally low blood pressure, in their surgical and critical care patients before it occurs. HPI is only compatible with Edwards' minimally invasive, hemodynamic monitoring solutions.

Analgesic Solutions, a consulting and clinical research company with a focus in trails involving pain management, has introduced a central statistical surveillance tool for the monitoring of assay sensitivity within clinical trials.